1. Home
  2. WST vs EXPD Comparison

WST vs EXPD Comparison

Compare WST & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EXPD
  • Stock Information
  • Founded
  • WST 1923
  • EXPD 1979
  • Country
  • WST United States
  • EXPD United States
  • Employees
  • WST N/A
  • EXPD N/A
  • Industry
  • WST Medical/Dental Instruments
  • EXPD Oil Refining/Marketing
  • Sector
  • WST Health Care
  • EXPD Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • EXPD Nasdaq
  • Market Cap
  • WST 18.0B
  • EXPD 15.3B
  • IPO Year
  • WST N/A
  • EXPD N/A
  • Fundamental
  • Price
  • WST $272.51
  • EXPD $123.51
  • Analyst Decision
  • WST Strong Buy
  • EXPD Sell
  • Analyst Count
  • WST 8
  • EXPD 10
  • Target Price
  • WST $333.71
  • EXPD $114.67
  • AVG Volume (30 Days)
  • WST 675.2K
  • EXPD 1.2M
  • Earning Date
  • WST 10-23-2025
  • EXPD 11-04-2025
  • Dividend Yield
  • WST 0.32%
  • EXPD 1.25%
  • EPS Growth
  • WST N/A
  • EXPD 31.92
  • EPS
  • WST 6.68
  • EXPD 6.14
  • Revenue
  • WST $2,960,200,000.00
  • EXPD $11,273,140,000.00
  • Revenue This Year
  • WST $6.28
  • EXPD $2.72
  • Revenue Next Year
  • WST $6.02
  • EXPD $0.39
  • P/E Ratio
  • WST $40.77
  • EXPD $20.11
  • Revenue Growth
  • WST 2.90
  • EXPD 23.70
  • 52 Week Low
  • WST $187.43
  • EXPD $100.47
  • 52 Week High
  • WST $352.33
  • EXPD $129.15
  • Technical
  • Relative Strength Index (RSI)
  • WST 66.82
  • EXPD 57.60
  • Support Level
  • WST $249.76
  • EXPD $120.78
  • Resistance Level
  • WST $262.90
  • EXPD $123.14
  • Average True Range (ATR)
  • WST 6.38
  • EXPD 2.14
  • MACD
  • WST 1.40
  • EXPD -0.04
  • Stochastic Oscillator
  • WST 83.27
  • EXPD 56.13

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EXPD Expeditors International of Washington Inc.

Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: